Showing results (1021-1030 of 3,150) with videos related to
Sort By:
Pageof 315
Neuro-Oncology|September 5, 2012
Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1Chii-Wen Chou, Chi-Chung Wang, Chung-Pu Wu, et al.Neuro-Oncology|September 7, 2012
Outcomes of the oldest patients with primary CNS lymphoma treated at Memorial Sloan-Kettering Cancer CenterMary R Welch, Antonio Omuro, Lisa M DeangelisNeuro-Oncology|September 7, 2012
Clinical and neuroanatomical predictors of cerebellar mutism syndromeNicole Law, Mark Greenberg, Eric Bouffet, et al.Neuro-Oncology|October 24, 2012
Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutationJelena Lazovic, Horacio Soto, David Piccioni, et al.Neuro-Oncology|October 26, 2012
Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practiceMichael Weller, Roger Stupp, Monika E Hegi, et al.Neuro-Oncology|October 26, 2012
Cerebral white matter integrity and executive function in adult survivors of childhood medulloblastomaTara M Brinkman, Wilburn E Reddick, Joshua Luxton, et al.Neuro-Oncology|October 26, 2012
Radiation-induced cognitive impairment--from bench to bedsideDana Greene-Schloesser, Mike E RobbinsNeuro-Oncology|October 26, 2012
Factors influencing quality of life in adult patients with primary brain tumorsRakesh Jalali, Debnarayan DuttaNeuro-Oncology|October 26, 2012
Working memory and the identification of facial expression in patients with left frontal gliomaYong-Gao Mu, Ling-Juan Huang, Shi-Yun Li, et al.Neuro-Oncology|October 27, 2012
Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02Eudocia Q Lee, John Kuhn, Kathleen R Lamborn, et al.Pageof 315